FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML. (Q33680292)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML. |
scientific article |
Statements
1 reference
FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML. (English)
1 reference
Keith W Pratz
1 reference
Takashi Sato
1 reference
Kathleen M Murphy
1 reference
Adam Stine
1 reference
Trivikram Rajkhowa
1 reference
Mark Levis
1 reference
10 December 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference